Decibel Therapeutics

decibeltx.com

Total Raised

$189M

Investors Count

Deal Terms

Funding, Valuation & Revenue

7 Fundings

Decibel Therapeutics has raised $189M over 7 rounds.

Decibel Therapeutics's latest funding round was a Acq - P2P for on September 25, 2023.

Decibel Therapeutics's valuation in February 2021 was $393.12 - $393.17M.

Decibel Therapeutics's latest post-money valuation is from September 2023.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
9/25/2023	Acq - P2P		Regeneron	$XXM	0 FY undefined	4
2/12/2021	IPO	$XXM	Subscribe to see more	$393.12 - $393.17M	0 FY undefined	10
11/9/2020	Series D	$XXM	Subscribe to see more	$XXM	0 FY undefined	10
6/19/2018	Series C	$XXM	Subscribe to see more	$XXM	0 FY undefined	10
7/6/2017	Series B		Subscribe to see more	$XXM	0 FY undefined	10

Date	9/25/2023	2/12/2021	11/9/2020	6/19/2018	7/6/2017
Round	Acq - P2P	IPO	Series D	Series C	Series B
Amount		$XXM	$XXM	$XXM
Investors	Regeneron	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Valuation	$XXM	$393.12 - $393.17M	$XXM	$XXM	$XXM
Revenue	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined
Sources	4	10	10	10	10

Decibel Therapeutics Deal Terms

3 Deal Terms

Decibel Therapeutics's deal structure is available for 3 funding rounds, including their Acq - P2P from September 25, 2023.

Round	Acq - P2P	IPO	Series A
Funding Date	$XXM	$XXM	$XXM
Pre-Money Valuation		$XXM
Post-Money Valuation	$XXM	$XXM	$XXM
Amount Raised		$XXM	$XXM
Shares Authorized
Issuance Price			$XXM
Dividend Rate			$XXM
Liquidation Preferences			$XXM
Liquidation Price
Participation
Conversion Price
Anti Dilution			$XXM
General Voting	$XXM	$XXM	$XXM
Board Voting	$XXM	$XXM	$XXM
Par Value

Round	Funding Date	Pre-Money Valuation	Post-Money Valuation	Amount Raised	Shares Authorized	Issuance Price	Dividend Rate	Liquidation Preferences	Liquidation Price	Participation	Conversion Price	Anti Dilution	General Voting	Board Voting	Par Value
Acq - P2P	$XXM		$XXM										$XXM	$XXM
IPO	$XXM	$XXM	$XXM	$XXM									$XXM	$XXM
Series A	$XXM		$XXM	$XXM		$XXM	$XXM	$XXM				$XXM	$XXM	$XXM

Decibel Therapeutics Investors

18 Investors

Decibel Therapeutics has 18 investors. Regeneron invested in Decibel Therapeutics's Acq - P2P funding round.

First funding	Last Funding	Investor	Rounds	Type	Location
6/19/2018	9/25/2023	Regeneron	2 Series C, Acq - P2P (2023)	Corporation	New York
10/15/2015	11/9/2020	SR One	3 Series A, Series C (2018), Series D (2020)	Venture Capital	Pennsylvania
7/6/2017	11/9/2020	Google Ventures	3 Series B, Series C (2018), Series D (2020)	Corporate Venture	California
00/00/0000	00/00/0000	Third Rock Ventures	Subscribe to see more	Venture Capital	Massachusetts
00/00/0000	00/00/0000	Foresite Capital	Subscribe to see more	Venture Capital	California

First funding	6/19/2018	10/15/2015	7/6/2017	00/00/0000	00/00/0000
Last Funding	9/25/2023	11/9/2020	11/9/2020	00/00/0000	00/00/0000
Investor	Regeneron	SR One	Google Ventures	Third Rock Ventures	Foresite Capital
Rounds	2 Series C, Acq - P2P (2023)	3 Series A, Series C (2018), Series D (2020)	3 Series B, Series C (2018), Series D (2020)	Subscribe to see more	Subscribe to see more
Board Seats
Type	Corporation	Venture Capital	Corporate Venture	Venture Capital	Venture Capital
Location	New York	Pennsylvania	California	Massachusetts	California

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.

How VCs Use CB Insights

Professional Services

Platform Overview